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Abstract  
 
Purpose: Human immunodeficiency virus (HIV) infection could potentially play an important role in the 
management of fractures as they have been shown to affect fracture healing and the post-operative risk of implant 
sepsis.  
 
Methods: A systematic review of the relevant literature was performed on PubMed and Scopus databases. Twenty-
six studies were identified, critiqued and analysed accordingly.  No randomised controlled trials were identified.  
 
Results: HIV positivity was not shown to influence an individual’s risk of early wound infection in operatively 
managed closed fractures. The rate of pin track infection in open injuries managed with external fixators was low. 
However, in open injuries managed with internal fixation, early wound infection rates were increased in the HIV-
positive population compared to HIV-negative individuals. Regarding late implant infection, in closed fractures 
there appeared to be no increased risk of infection but there is limited evidence for open injuries. Additionally, 
further evidence is needed to establish if the rate of union in both open and closed fractures are influenced by HIV 
status.  
 
Conclusion: Overall, no evidence was found to suggest that surgical management of fractures in the HIV population 
should be avoided, and fixation of closed fractures in the HIV population appeared to be safe. The effect of anti-
retroviral therapy is unclear and this should be further researched. However, based on the limited evidence, caution 
should be taken in the management of open fractures due to the potentially increased infection risk. The impact of 
anti-retroviral therapy on the outcomes of surgery needs further evaluation. 
 
Keywords: HIV; ART; Fracture; infection; union  
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1. Introduction 
 
Worldwide approximately 35.3 million people are Human Immunodeficiency Virus (HIV) positive, with the highest 
prevalence seen in Sub-Saharan Africa [1]. The introduction of Anti-Retroviral Therapy (ART) in 1997 altered the 
course and nature of patients infected with HIV by increasing the duration of asymptomatic infection and increasing 
life expectancy [2,3]. ART is a combination of medication given to those affected with the disease. This suppresses 
the viral load and improves the patient immunological status [4]. A 50% reduction in morbidity and mortality has 
been reported in those with a CD4 T-cell count of >500cells/mm3 and have been started on ART promptly [5,6]. 
However, despite near normal life expectancy, there is little evidence to advise the surgeon and patient about the 
effect of long-term immunosuppression in HIV-positive patients and implant usage in orthopaedic surgery [7].  
 
HIV principally affects a patient’s immunological status by reducing the host CD4 T-cell count, resulting in an 
increase in the risk of a patient developing opportunistic infections. HIV has also been shown to affect other 
chemical mediators, including interleukins 1 and 6 and tumour necrosis factor, which have been shown to play a role 
in the fracture repair process [8-10]. 
 
HIV and ART have both been shown to reduce bone mineral density (BMD), bone mineralization and bone turnover 
[11-15]. In the general population, it has been postulated that a reduced BMD is associated with a reduced speed of 
fracture healing [16]. If this relationship were to hold true in the context of HIV, then positive individuals would not 
only be at an increased risk of fragility fracture, but also of subsequent delayed fracture healing and failure of 
fracture fixation.  
 
A major factor known to affect fracture healing is local blood flow to the site of the injury. It is now well established 
that any stage of HIV infection is associated with osteonecrosis, due to interruption in osseous blood supply, 
although no mechanism for this has been shown [17-19]. ART has also been reported to contribute to this pathology 
[18]. Conditions that jeopardize arterial flow to the site of primary bone healing are associated with higher rates of 
delayed fracture healing and non-union [20-22]. 
 
A small number of studies have investigated the role of HIV in the fracture healing process.  These have suggested 
that HIV and/or ART are associated with delayed fracture healing and may result in non-union [23,24]. The 
molecular and cellular mechanisms driving this remain unclear and the true effect of HIV and ART on bone healing 
is very poorly understood. 
   
The aim of this study is to undertake a systematic review of the outcomes of operative treatment of fractures in HIV 
positive individuals. A formal meta-analysis could not be carried out due to the significant variability in the 
methodology and outcome measures in each study. 
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2. Methods 
The search strategy was formulated with key-concepts identified using the Population, Intervention, Comparator and 
Outcome (PICO) process[25] to identify search-terms. These were exploded to include synonyms, alternative 
spellings and related terms. MeSH (Medical Subject Headings) were combined using a Boolean technique to 
improve the search [26,27]. Specific terms and limitations were subsequently introduced and combined to refine the 
search [28]. 
Both PubMed and Scopus databases were searched as no single database covers all the resources within a given field 
[29].  
The last search was carried out on 24th March 2016. The eligibility criteria are listed in Table 1. 
Backward referencing of eligible studies and existing reviews were carried out to increase the number of relevant 
studies. Abstracts of relevant orthopaedic journals and HIV/Acquired Immune Deficiency Syndrome (AIDS) 
conferences were included to increase the number of studies.  
The systematic review was carried out according to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidance [30]. The process of the literature search is summarised in Figure 1. The search 
yielded a total of 26 studies, which were included in this systematic review. Studies that met the inclusion criteria 
were summarised onto a spreadsheet to extract data. The summary consisted of study results, methods, limitations 
and treatment centres so that readers may interpret the resource context and compare outcomes between centres. 
 
3. Results 
3.1 Early Infection 
3.1.1. Closed fractures 
There were 7 studies that investigated early wound infection and/or early implant sepsis in closed fractures managed 
with open reduction and internal fixation (Table 2). The time period that was used to assess infection varied between 
studies. In this systematic review, early wound infection was defined as an ASEPSIS[31] score >10 as this would 
suggest a disturbance of wound healing [31]. This same definition of an ASEPSIS score of greater than 10 was used 
by the Malawi group [31]. However, the definition used in the other studies was not consistent [32,24,33-37].  
In a retrospective single blind study, Paiement et al[32] from San Francisco, USA, reported a zero wound infection 
rate for closed fractures for HIV positive patients (n=14) whereas in the HIV negative control group (n=446) it was 
4%. As ART status was not mentioned, and as this study was carried out in the pre-ART era it was assumed that 
none of the patients were on ART.  
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Similar results were reported by Harrison et al[24], from Malawi, in a prospective single blind study. They reported 
the results of a larger study population of 28 that were also ART naïve and a control HIV-negative group of 108. 
Wound infection rates were 4% and 6% respectively, which were not statistically significant. It was noted that 35% 
(n= 38) of the HIV population had CD4 counts <200.  
Bahebeck et al[34] from Cameroon, demonstrated an infection rate of 5% (n=74) in his HIV-positive study group 
compared to 1% (n=572) in the HIV-negative control group.  This study prospectively analysed a cohort of patients 
with closed injuries that underwent surgery for fresh fractures, non-union, malunion, aseptic necrosis, and 
osteoarthritis. Fresh fracture was the most common indication. Prior to surgery, 5% were on ART, which increased 
to 59% (n=74) at follow-up. Forty-four patients had a CD4 count <500 and were considered immunodeficient. They 
were started on ART at the time of injury. 
In the largest prospective single blind study, researchers from Malawi reported the outcome of 118 HIV-positive 
cases and 418 controls [36]. They reported wound infection rates of 4% in HIV-positive patients and 6% in the 
control group, which was not statistically significant different. In this study 5% of the 118 HIV-positive patients 
were initially on ART, which later increased to 16% post-operatively. 
Similar overall rates were reported by Nawale et al[33] 2006 from Pune, India in a retrospective analysis of 35 
patients, in both ART naïve HIV-positive and control groups. Their wound infection rates were 6% (n=35) and 
4%(n=35) respectively. 
The most recent study carried out by Hao et al[37] (Denver, USA), did not use the ASEPSIS score  to define 
infection. Instead the surgical site infection (SSI) was used (Centre for disease Control/ National Healthcare Safety 
Network). In 24 patients with HIV, majority of patients were taking ART (92%,n=22) at the time of injury. One 
patient developed a SSI, resulting in a 4% rate of early wound infection in this cohort. 
Not all researchers have found low rates of infection. Abalo et al[35] (Togo) reviewed HIV-positive patients with 28 
closed fractures managed with open reduction and internal fixation. They reported an infection rate of 29%. Prior to 
surgery, 35% of the patients were on ART. No control group was reported. 
3.1 2. Open fractures 
 Wound infection 
Fourteen studies examined wound infection in HIV-positive patients managed operatively after open fractures 
(Table 3). These studies were extremely heterogeneous in design. Varying definitions of wound infection were used 
and in some studies the methods of determining wound infection rates were not stated. An array of fixation methods 
and injuries were included and commonly the grade of open injury was not defined. When external fixators were 
used to manage injuries, it was not always clear to determine if wound infection rates were referring to pin track 
infections or infection around the fracture site. Furthermore, the vast majority of studies were retrospective and 
patients were followed up for different lengths of time.  
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Howard et al[38] from Empangeni, South Africa studied open tibial fractures and reported an early wound infection 
in 11%(n=28) of their HIV-positive group; in comparison to the control group, which had a rate of 20%(n=57). 
Among the HIV-positive cohort the mean CD4 count was 432 and only 11% (n=28) patients were on ART. In a 
prospective analysis by Aird et al[39] from the same research group, 35 ART naïve patients underwent various 
methods of internal and external fixation following open injuries. The rate of early wound infection in this group 
was 15% (n=33), whereas the HIV-negative group had a 22%(n=86) infection rate, giving a risk ratio of 0.69. It is 
important to note that Aird et al results showed variation infection rates among the Gustilo-Anderson grades, with 
higher rates of infection in grade-I and-II, compared to III. Similar wound infection rates of 5%(n=39) were reported 
by Nawale et al[33] and other smaller cohorts have echoed these results. [40,41]  
Conversely, Bates et al[36] from Malawi studied 21 HIV-positive patients in a prospective single blind cohort study 
who had undergone a number of different forbms of fixation, including K-wire, screws, plates and nails. The 
infection rate was 33% in their study population, while the HIV-negative control group had an infection rate of 15% 
(n=81). Only 5%(n=21) of their study cohort were on ART preoperatively, which increased to 16% post-operatively.  
The majority of the smaller studies (i.e. < 20 patients) demonstrated high rates of infection in patients managed 
operatively following open fractures.[24,32,35,33,42,43] However caution needs to be used when interpreting their 
results due to the small numbers.  
 Pin track infection   
Four studies focussed on analysing the incidence of pin track infections in HIV-positive patients managed with 
external fixators following open fractures (Table 3). They all classified the pin track infections using the 
Checketts[44] scoring system. Howard et al[38] (Empangeni, South Africa) studied 17 HIV-positive patients and 
found severe (grade-V or -VI) pin track infection rate of 18%, whereas the infection rate for the HIV-negative 
control group of 40 patients had an infection rate of 13%. In the retrospective study by Ferreira et al[45] 
(Pietermaritzburg, South Africa) pin track infections of a Checketts score >II were studied.  The pin track infection 
rate was 20% in their HIV-positive study population of 40 patients (63% of whom were started on ART post 
operatively). They reported a similar infection rate of 21% in a larger HIV-negative cohort (n=168). A third group of 
participants of unknown HIV status HIV had pin track infection rate of 24%. There was no statistically significant 
difference for incidence or severity between the three groups. 
Norrish et al[46] (Malawi) studied 15 HIV-positive patients stabilised with external fixation, who were not on ART. 
This group had a pin track infection rate (Checketts score>II) of 60% compared to 20% in the HIV-negative control 
group of 35 patients. Only one patient needed a surgical intervention. Harrison et al 2004[47] observed a 75% rates 
of pin track infection in 7 cases while in 21 controls in their study had infection rates of 19%.   
3.2 Long-term outcomes 
3.2.1 Late implant sepsis 
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There were 5 studies that examined late implant sepsis in closed and open fractures (Table 4). We defined late 
implant sepsis as deep infection, which became evident 6 or more months after index surgery. 
In prospective studies, Harrison et al 2004[48] (n= 26) and Graham et al[49] (n=103) (both Malawi) reported that 
there were no late implant infections for closed fractures; the mean follow up in these studies was 12 and 27 months 
respectively. No patient was on ART in the Harrison study and treatment rates was 8% pre-operatively and 27 % 
post-operatively in the Graham study. 
In a prospective study carried out by Keetse et al[50] (Empangeni, South Africa) 12-month late implant sepsis rates 
were 3% for both HIV-negative (n=120) and HIV-positive (n=40) groups. Brijlall[51] (Durban, South Africa) found 
that 18 of  21 late implant infections were seropositive for HIV;  patients presented a mean of 24 months (no range 
given) after index surgery. Neither of the studies stated the definition of late implant sepsis which could have had a 
major bearing on the recorded rates of infection.  
In terms of late sepsis after open fractures, Graham et al[49] did not find any cases in twelve patients. Phaff et al 
[52] (Empangeni, South Africa) had a late implant sepsis rate of 8% in both the HIV-positive study population, and 
the HIV-negative cohort.  
3.2.2 Non-union 
In the non-union studies, a clear definition of the method for determining fracture union either radiologically or 
clinically was not documented, making accurate interpretation of the results difficult. There was also a large 
variation in duration of follow up, showing the lack of consistency of these studies. Defining union is challenging 
due to the lack of standardised assessment methods and even though radiological evaluation was carried out in most 
studies, no validated tool was used to assess union.  For this review, a delayed union was defined as a fracture that 
was not healed at 6 months and a non-union was defined as a fracture that had not healed at 12 months. Clinically, 
union was considered to be present if there was return of function and weight bearing and a pain free range of 
motion, whereas for radiographic union 3 out of the 4 cortices on anterior-posterior and lateral X-rays had to be 
bridged. 
 Non-union in closed fractures 
Eight authors studied non-union in closed fractures, with a mix of prospective[48,50,53] and retrospective studies 
[35,54]. (Table 5) 
The rates of non-union were 0% in 26 HIV-positive ART naïve patients that were clinically and radiologically 
evaluated in Malawi[48] and 5% in 95[53], 6% of whom were on ART; Keetse et al[50] (South Africa) looked at 40 
closed femoral fractures that had undergone intramedullary nailing, however the method of evaluation of non-union 
was not described. Only one patient of the study group was on ART at the time of follow-up. None of the 40 patients 
developed non-union, whereas in the HIV-negative control group (n=120), had a rate of non-union of 2%.  
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Abalo et al[35] did not describe their definition of non-union, but reported rates of 11%(n=4) in an HIV-positive 
group of 36 patients. Cummins et al[54], in their retrospective study, also failed to give their definition of non-union, 
but reported that 3 of the 4 HIV-positive patients had non-union. Hao et al[37] followed a cohort of 24 HIV positive 
patients with closed fractures, none of whom developed non-union even though 92% of the patients were on ART.  
Babruam[42] (Durban, South Africa) followed up 11 closed fractures in his study group of ART naïve patients that 
underwent intramedullary fixation and showed that all had united by four months. Brijlall[51] (Durban, South 
Africa) looked at an ART naïve cohort of 18 patients with infected implants postoperatively that presented late and 
found a rate of non-union of 11%. Neither Babruam[42] nor Brijlall[51]  mentioned the method of evaluation of 
non-union. 
 Non-union in open fractures 
Six authors looked at non-union in open fractures. Aird et al[55] (Empangeni, South Africa) reported rates of non-
union of 15%(n=33) for HIV-positive group and 4%(n=100) in the HIV-negative control group. However the 
method of evaluation, length of follow-up, grade of open fracture and energy of the initial injury were not clearly 
recorded. Furthermore, risk factors for non-union such as diabetes and smoking were not recorded. 
In the prospective analysis of 13 individuals by Phaff et al[52] from the same study group as Aird, the rate of non-
union was 8%(n=1). There was 1 patient who was on ART at the time of follow-up, who did not develop a non-
union. In this study, which had a 39 month follow up, the rate of non-union in the HIV-negative control group was 
0%(n=24). Participants underwent procedures that included intramedullary nails, plates, screws and tension band 
wiring. Union was assessed both clinically and radiographically in this study.  
A retrospective study by Nawale[56] on 39 patients, not on ART, demonstrated rates of non-union of 10%. In the 5 
patients Gardner et al[53] described a non-union rate of 20%. These three authors assessed patients for non-union on 
radiological imaging.  
Prospective single blind cohort studies by Harrison et al[47] in 2004 and Babruam[42] followed patients up for less 
than 12 months, hence not fulfilling our criterion of non-union. Harrison et al[47] in 2004 followed their patients up 
for 6 months using clinical evaluations and radiographs. They reported a 43%(n=3) rate of delayed union in a 7 
patient study group. Babruam[42] followed three patients who were HIV-positive for 4 months and reported that 1 
patient (33%) did not show fracture union at the end of follow up, whereas the 2 HIV-negative patients had full 
fracture union. 
 
Discussion 
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There have been a number of well-designed studies with appropriate length of follow up and number of patients that 
have evaluated early infection in closed fractures, demonstrating no increased risk of infection in patients with HIV 
[34,33,36]. 
In the pin track infections, all studies showed little difference between the HIV-positive and HIV-negative 
population, although the overall numbers of patients looked at were relatively small [44]. 
Mixed results have been reported for early wound infection rates in HIV patients with open fractures. Aird et al 
documented the largest study with lower rates of wound infection in the HIV-positive patients compared to HIV-
negative control, but had variation among the Gustilo-Anderson grades. Patients with a grade-I Gustilo-Anderson 
had a delay in debridement in their study, which could account for the higher rates of infection observed in the 
grade-I open fractures. Excluding Howard’s study, all the other studies reported an increased risk in the HIV-
positive patients following open fractures. The varying quality of the studies reported so far make it difficult to draw 
clear conclusions, and more well designed and standardised studies including Gustilo-Anderson grading are needed.  
The studies reviewed reported low rates of late implant sepsis in the HIV positive patients with closed fractures. In 
open fractures, there was too little data on late implant infection to draw valid conclusions 
In all of the studies evaluated there was a lack of a clear definition of non-union to allow consistent evaluation 
between the studies. Fracture union is dependent on a huge number of different variables.[57,58]. All the studies 
evaluated were of poor study design, with no fixed definition of union and none used a validated radiological 
scoring system for bone union, such as the RUST Score [59,60]. Therefore, it is difficult to draw any valid 
conclusions from the studies reviewed.  
Previous basic science research has suggested that HIV infection may associated with delayed and nonunion of 
fractures [23]. Researchers have hypothesized that altered cytokine environment arising from HIV infection may 
modify the inflammatory response which subsequently triggers the process of bone healing. There is increasing 
evidence to suggest that HIV seropositivity alone affects bone turnover, and in particular, may inhibit bone 
formation, which could contribute to issues with union. Furthermore, reports of osteonecrosis in HIV-positive 
patients without other risk factors poses the question as to whether HIV may compromise the reliability of the blood 
supply required for fracture healing [23]. 
Despite this fact, the studies evaluated suggest that non-union in closed fractures may not be a major concern in the 
HIV-positive individual. However, there is a need for further studies to be undertaken, using validated and accurate 
primary outcomes measures for bone union, in order to draw any valid conclusions. In open fractures there is also 
insufficient evidence to comment on bone union rates.  
Most studies have not included enough patients on ART to draw meaningful conclusions. There has been an 
association shown between issues of non-union and the use of ART [23]. However, the multiple sources of 
heterogeneity such as duration of treatment, different drug regimens and differing degrees of immunosuppression 
9 
 
make it difficult to truly assess the effect. ART might also be expected to improve wound infection rates after open 
fractures and to reduce late implant sepsis in HIV-positive individuals, but current data lacks power to enable any 
such conclusions to be drawn. 
The two largest surgeon study groups were from Africa. Hospital conditions and access to ART is substantially 
different to that of high-income countries. Caution should therefore be applied before direct extrapolation of 
published results to high-income settings.  
Our study inclusion criteria ensured that all available literature was analysed, including abstracts that were not 
published as full papers, resulting in some loss of detail relating to study design and definitions. Other limitations 
were that any articles that were not in the English language were excluded.  
It should be noted that supervision of this review came from the Harrison study group in Malawi, which could have 
been a potential source for bias. The first author and study selector made no reference to the principal researchers 
whilst searching and selecting studies so as to offset this possible bias. 
 
Conclusions 
Our study confirms that the surgical management of fractures in the HIV-positive groups should not be avoided. The 
outlook in the closed fractures is very encouraging, as it appears comparable to results obtained in HIV negative 
patients with equivalent injuries. The effect of ART on bone healing is uncertain and has not been sufficiently 
investigated. There are areas where more research is necessary, in particular the effect of HIV and ART on wound 
infection rate after open fractures, as well as the impact of HIV and ART on fracture union. 
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Table 1 Inclusion and exclusion criteria  
 
 
Type of criteria Description Rationale for criterion 
Inclusion Criteria 
Short or long terms patient outcomes or both 
post-operative management of fractures in HIV 
or AIDS (acquired immunodeficiency 
syndrome). 
As per research question. 
Where indication for surgery were not fresh 
fractures, such as malunion, revision surgery, 
arthrodesis and arthroplasty were included as 
long as the majority of the procedures were 
fracture fixations. 
This is to maximise the 
includible literature. 
Where multiple articles from the same study 
have been published more than once, only the 
single best study article was chosen unless 
subsequent publications included new data 
 
Studies produced in the last 25 years.  
Exclusion Criteria 
If spinal surgery/ maxillofacial surgery/ 
arthroplasty were the only focus of the study. 
As per research question. 
No numerical data presented in the HIV 
positive category. 
This is required to make a 
comparison of results among 
studies. 
If the early complications were not categorised 
into open and closed fractures. 
This categorisation provides 
sufficient information for the 
results to be applicable to 
certain patient groups. 
Case reports Epidemiological evidence 
carried forth by case reports are 
very minimal. 
Languages other than English. Obtaining translations solely for 
this review was not financially 
feasible. 
Table 1 Click here to download Table Table 1 Inclusionand exclusion
criteria.docx
Table 2 Early infection in closed fractures 
Key: P- Prospective study; PSB- Prospective single blind study; R- retrospective study; RSB- Retrospective single blind study 
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Definition 
of early 
infection 
Outcome-  
Wound infection 
HIV staging categories Statistical analysis 
Standard 
methods of 
evaluation 
Limitations Notes 
Study  Control 
G.D. 
Paiement 
[27] 1994 RSB 
USA (San 
Francisco) 6.5 
0/14 
[0%}* 
0/14 
[0%]* 30 days 
0/14 
[0%] 
14/446 
[4%] - 
P=0.035, Chi-square in HIV 
positive group and wound 
infection CDC definition Retrospective 
*No mention if 
patient were on 
HAART therefore 
assumed as not 
on HAART 
W.J. 
Harrison [19] 2002 PSB 
Africa 
(Malawi) 3 
0/28 
[0%] 
0/28 
[0%] 3 months 
1/28 
[4%] 
6/108 
[6%] 
WHO staging, 
Stage 0= 2[80%], stage 1=3[8%], 
stage 2=2[5%], stage 3=2[5%] not 
known= 1[2%]; 
 
CD4 cell counts >500= 16%, 
 200-500= 49%, <200=35% 
P value for closed fractures 
between HIV positive vs HIV 
negative =0.396. Not significant. 
ASEPSIS 
wound score 
>10. - 
Contained a mix 
of patients with 
open and closed 
fractures 
S. Nawale 
[28] 2006 R Asia (India) N/M 
0/35 
[0%] 
0/35 
[0%] N/M 3/35 [9%] 
2/35 
[6%] 
CD4 counts were between250-500. 
Values not mentioned.  NM 
ASEPSIS 
wound score. 
Value not 
mentioned. Retrospective. Not blind.  
Follow up period 
not defined.  
J. Bahebeck 
[29] 2008 P 
Africa 
(Cameroon) 3 
3/74 
[5%] 
44/74 
[59%] 3 months 
4/74 
[5%] 
3/572 
[1%] CD4 > 500= 30[41%], <500= 44[60%] 
Fisher’s exact test significant if 
<0.05, value =0.87 N/M 
Not blinded,no standard 
use of scores such as 
ASEPSIS to measure 
infection. 
Mixed cohort of 
patients. Majority 
were fresh 
fractures 
A. Abalo [30] 2010 R Africa (Togo) 27 
 16/36 
[44%] ▲ 
16/36 
[44%] ▲ N/M 
8/28 
[29%] - 
CD4>500= 21[58%], 200-
500=12[33%], <200=3[8%] infection 
rates higher in symptomatic  
P value <0.05 sig P for CD4 
counts >2 = 0.041 N/M 
No control. 
Retrospective. Not 
blinded. NO standard 
methods of ASEPSIS 
score used to measure 
infection. 
 ▲ HAART 
assumed to be 
prior to injury.  
J. Bates [31] 2012 PSB 
Africa 
(Malawi) 1.5 
7/139 
[5%] 
22/139 
[16%] 6 weeks 
5/118 
[4%] 
25/418 
[6%] 
 
CD4>500= 27[22%], 500-200= 
69[56%], >500=28[23%] no 
relationship between ASEPSIS and 
CD4 count 
P value <0.05 significant, HIV 
positive open vs HIV negative 
p=0.064. Not significant 
ASEPSIS 
wound score 
>10. 
Follow up of only 6 
weeks  
J. Hao [32] 2015 P 
USA 
(Denver) 12 
22/24[92
%] 22/24[92%] 3 months 1/24 [4%] - 
CD4>500 =6[28%], 200-
500=10[48%], <200=5[24%] N/M 
SSI- 
CDC/NHSN 
classification 
High loss to follow-up. 
No control. Small 
sample size. Not 
blinded. Abstract. - 
Table 2 Click here to download Table Table 2 Early infection in closed fractures (1).docx 
Table 3 Wound infection and open fractures (fracture management inclusive of internal fixation and external fixation) 
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Definition of 
early 
infection 
Outcome 
HIV staging categories Statistical analysis 
Standard methods of 
evaluation 
Limitations Notes 
 
Wound infection 
 
Pin track infection 
Study Control Study Control 
G.D. Paiement 
[27] 1994 RSB 
USA (San 
Francisco) 6.5 
- 
0/11 
[0%]* 30 days 4/11 [36%] 
10/118 
[9%] - - 
- P=0.035, Chi-square CDC definition Retrospective 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
E.D. O’Brien 
[38] 1994 R 
USA (New 
York) 
Range 
6-24 
- 
0/4   
[0%]* 
Range 6-24 
months 4/4 [100%] 1/11 [9%] - - 
- - - 
Retrospective. Small 
study group.   Abstract. 
Follow up period not defined.         
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
W.J. Harrison 
[19] 2002 PSB 
Africa 
(Malawi) 3 0/12     
[0%] 
0/12  
[0%] 3 months 5/12 [42%] 3/27 [11%] - - 
WHO staging,                stage 0= 
2[80%],           stage 1=3[8%],              
stage 2=2[5%],             stage 
3=2[5%]                  not known= 
1[2%];  
CD4 cell counts >500= 16%, 200-
500= 49%,       <200=35% 
P value for open #s HIV positive 
versus negative =0.084 
ASEPSIS wound score 
>10.  - 
Contained a mix of patients 
with open and closed 
fractures. 
W.J. Harrison 
[42] 2004 PSB 
Africa 
(Malawi) 6 
0/7       
[0%] 
0/7   
[0%] 3 months - - 
5/7        
[71%] 4/21   [19%] 
WHO staging- 0=4[57%], 
1=1[14%], 2=2[29%] 
 CD4 count <200= 2 [29%], 200-
500= 2[29%], >500=[14%]              
unknown 2[29%] 
P value for infection= 0.02 was 
significant Pin track- Checketts Small study population  
F.F. Birkholtz 
[35] 2005 P 
Africa (South 
Africa) N/M 
0/16 
[0%]* 
0/16 
[0%]* N/M 0/3   [0%] 5/16 [31%] - - 
N/M N/M N/M 
Very small study 
population.  Not 
blinded. Abstract. No 
standard method of 
measuring outcome 
such as ASEPSIS 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
Table 3 Click here to download Table Table 3 Wound infection and open fractures.docx 
A. Baburam [37] 2005 PSB 
Africa (South 
Africa) 4 
0/3[0%]
* 
0/3 
[0%]* 4 months 1/3 [33%] 0/2   [0%] - - 
N/M N/M All fractures GA grade-II 
Abstract. Follow up 
only 4 months, which is 
not sufficient to 
measure long-term 
outcomes. No standard 
method of measuring 
outcome such as 
ASEPSIS 
Follow up period was 
mentioned but assumed to be 
4 months according to what is 
mentioned in abstract. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
A. Baburam [36] 2005 PSB 
Africa (South 
Africa) 
Mean 
7.3  
(range1-
14) 0/10  
[0%] 
0/10  
[0%]* 
7.3  (range1-
14) 
1/10 [10%]   
GA 
grading I- 
0/1, II- 0/3, 
IIIa-1/3, 
IIIb-0/3 
1/8 [13%]   
GA 
grading II-
0/5, IIIa-
0/1, IIIb-
1/2  - - 
N/M 
P=0.641 not statistically significant. 
P value given for infection rate in 
HIV positive versus HIV negative N/M 
Abstract.  No standard 
method of measuring 
infection e.g. ASEPSIS 
score. Distribution of 
open fractures not 
evenly distributed in 
HIV positive and HIV 
negative groups.  
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
S. Nawale [28] 2006 R Asia (India) N/M 0/14 
[0%] 
0/14 
[0%] N/M 8/14 [57%] 3/14 [21%] - - 
 
CD4 counts were between 250-
500. Values not mentioned. NM 
ASEPSIS wound score. 
Values not mentioned. 
Retrospective. Not 
blind. Follow up period not defined. 
S. Nawale [51] 2007 R Asia (India) 12 0/39 
[0%]* 
0/39 
[0%]* 1 year 2/39 [5%] - - - 
N/M N/M N/M 
No control. 
Retrospective. Not 
blinded. Abstract. No 
standard methods to 
measure outcomes 
such as ASEPSIS. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
A.R. Norrish [41] 2007 PSB 
Africa 
(Malawi) 2 
- 
0/15 
[0%]* 2 months - - 
9/15 [60%] 
Checketts 
II-7, III-1, 
IV-1 
7/35 [20%] 
Checketts II-
6, III-1 
N/M 
P value <0.05 significant, P= 0.01 
=> significant but P=0.07 when 
mean worst score / no of pin 
weeks=> not significant, 
For pin track infection 
Checketts. - 
Patients were followed up as 
long they had an External 
fixator in situ. Where the 
mean time was 2 months. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
A. Abalo [30] 2010 R Africa (Togo) 27 
16/36 
[44%] 
▲ 
16/36 
[44%]     
▲ 27 months 6/8 [75%] - - - 
CD4>500= 21[58%], 200-
500=12[33%], <200=3[8%] 
infection rates higher in 
symptomatic 
P value <0.05 sig P for CD4 counts 
>2 = 0.041 N/M 
No control. 
Retrospective. Not 
blinded. No 
standardised method of 
measuring outcomes 
e.g. ASEPSIS score. 
▲ HAART assumed to be 
prior to injury 
Key: P- Prospective study; PSB- Prospective single blind study; R- retrospective study; RSB- Retrospective single blind study 
N/M- not mentioned 
 
J. Aird [34] 2011 P 
Africa (South 
Africa) 3 - 
0/33 
[0%]* 30 days 
5/33 [15%]  
GA grade- 
abrasions- 
0/5,  I-
4/14, II-
1/9, IIIa- 
0/3, IIIb- 
0/2 
19/86 
[22%] GA 
grade- 
abrasion-
4/14,   I-
3/32, II-
4/17, IIIa-
3/12, IIIb-
4/11 - - 
CD4 < 350 =15[58%],      <100=0, 
7 patients were not measured due 
to disease denial. 
P value for infection= 0.49 in 
advanced HIV,- no statistical 
significance. Risk ration= 1.46[95% 
CI= 0.6-3.7; Risk of developing 
wound infection given HIV positivity, 
Risk ratio =0.69, 95% CI 0.3-1.7, P 
value 0.4. 
In HIV positive patients P value for 
abrasions =0.53, G.A. I= 018, G.A. 
II= 0.62 Risk ration (confidence 
interval) for G.A. I= 3.1(0.8-11), G.A. 
II=0.47(0.5-3.6). Values for other 
G.A. grading was not available. 
In Advanced HIV for G.A. I p value 
=0.02, risk ratio (confidence 
interval)= 6.33(1.8-23.0). Values for 
other G.A. grading were not 
available. ASEPSIS wound score. Not blinded. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
J. Bates [31] 2012 PSB 
Africa 
(Malawi) 1.5 
7/139 
[5%] 
22/139 
[16%] 6 weeks 7/21 [33%] 
12/81 
[15%] - - 
 
CD4>500= 27[22%], 500-200= 
69[56%], >500=28[23%] no 
relationship between ASEPSIS 
and CD4 count 
P value <0.05 significant, open HIV 
positive versus HIV negative 
p=0.064 not significant 
ASEPSIS wound score 
>10. 
Follow up of only 6 
weeks - 
N.E. Howard 
[33] 2013 P 
Africa (South 
Africa) 1-3 
3/28 
[11%] 
GA 
grading 
I-1, IIIa-
1, IIIb-1 
3/28 
[11%] 
GA 
gradin
g I-1, 
IIIa-1, 
IIIb-1 30 days 
3/28 [11%] 
GA 
grading II- 
2/11 
11/57 
[20%] GA 
grading II- 
3/40, III- 
7/17 
3/17 [18%] 
Only those 
with 
Checketts 
score >4 
5/40 [13%] 
Only those 
with 
Checketts 
score >4 
Mean CD4 = 432 (104-1190) no 
relationship between CD4 and 
ASEPSIS score. 4 had a 
CD4<350 
P value for wound infection in HIV 
positive p= 0.32, RR=0.55, 95% CI = 
0.17-1.8; P value for pin track=0.47, 
RR 1.62,95% CI 0.44 to 6.07, diff in 
wound infection rates between HIV 
positive and negative p=0.624 not 
statistically significant 
ASEPSIS wound score 
>10, Checketts score of 4 
for pin track infection. 
Not randomised, not 
blind, insufficient grade 
III #s , need more data 
on lower CD 4 i.e. <350 - 
N. Ferriera [40] 2014 R 
Africa (South 
Africa) 5 
0/40  
[0%] ◆ 
25/40 
[63%] 
◆ 
23 weeks 
(range 6-
104) - - 
8/40 [20%] 
Checketts- 
II-6, III-1, 
IV-1 
36/168 [21%] 
Checketts- II-
26, III-6, IV-2, 
VI-2 
Mean CD4=347.4, SD+/-162.4, 
range =82-682. No relationship 
between CD4 and infection P=0.9 no difference Checketts score. Retrospective 
◆ HAART assumed to be 
started post injury. 
Table 4 Late implant sepsis in Open and Closed fractures 
Author Year 
Study 
type 
Geographi
cal 
location 
Follow-up 
period 
(months) 
HAART 
prior to 
study % of   
patients 
HAART 
(%) at 
follow-up 
Outcome 
HIV staging 
categories 
Statistical 
analysis 
Limitations Notes 
Late implant sepsis 
Closed Open 
Study Control Study  Control 
S. Brijlall 
[46] 2003 R 
Africa 
(South 
Africa) - 
0/18    
{0%]* 
0/18    
{0%]* 18◇ - - - N/M N/M 
No control. No blinding. Follow 
up was not defined. Looked only 
at a cohort with infected 
implants. 
Follow up time not defined. Looked only 
at patients who were infected. Hence all 
18 patients had an implant sepsis. All 
cases that were looked at were also 
delayed presentation. 
◇Only patients with late implant sepsis 
were included  
*No mention if patient were on HAART 
therefore assumed as not on HAART 
W.J 
Harrison 
[43] 2004 P 
Africa 
(Malawi) 12  
0/26    
[0%]* 
0/26    
[0%]* 
0/26     
[0%] - - - 
CD4 
>500=7[27%], 
200-
500=8[31%], 
<200=9 [35%] N/M 
No control. No blinding. Follow 
up of only 12 months, not long 
enough for long-term outcomes. 
No standard method of scoring 
outcomes such as ASEPSIS 
*No mention if patients were on HAART 
therefore assumed as not on HAART 
M. Phaff 
[47] 2015 P 
Africa 
(South 
Africa) 
39                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
(mean) 
0/13
[0%} 
1/13
[0%} - - 
1/13     
[8%] GA 
grading 
abrasions 
0/3,  I-0/6,      
II- 0/3,   
IIIa- 0/0,
IIIb=1/1  
2/24      
[8%]        
GA grading 
abrasions 
0/5, I=1/11, 
II=0/3,   
IIIa- 0/3,
IIIb=1/2 
CD4>500=2 
[15%]       200-
500= 4 [31%]    
<200= 2[15%] 
Unknown=5[39
%] 
Relative risk 
in open 
fractures = 
0.92 
(Confidence 
interval 
0.092-9.2) 
P=1 (2 tailed 
Fischer exact
test) 
No control. Small sample size. 
Not blinded. No standard 
method of measuring outcome 
such as ASEPSIS. High rate of
loss to follow-up 
 
Only 1 patient was one HAART at follow
up. 
M.M. 
Keetse [45] 2014 P 
Africa 
(South 
Africa) 12  
12/40 
[30%] 
12/40   
[30%] 
1/40     
[3%] 
3/120   
[3%] - - 
CD4<350= in 7 
patients N/M 
Not blinded. Abstract. Follow up 
for only 12months which is not 
enough for long term outcomes 
Time HAART started not mentioned, so 
assumed to be prior to study. 
S. Graham 
[44] 2015 PSB 
Africa 
(Malawi) 27 (mean) 
7/103   
[6%] 
25/103 
[24%]  
0/93     
[0%] - 
0/12     
[0%] - 
CD4 > 500= 
21[23%] 200-
500=58 [62%], 
<200=14[15%] N/M 
No control, treatment was not 
blinded/ randomised beyond 
initial early postoperative period, 
cohort of young patients mean 
age 42, majority CD>200 
despite a low compliance with 
HAART  
Key: P- prospective study; PSB- Prospective single blind study; R- Retrospective study 
        N/M- Not mentioned 
Table 4 Click here to download Table Table 4 Late implant sepsis inOpen and Closed
fractures.docx
Table 5 Non-union in Open and Closed fractures 
Author Year 
Study 
type 
Geographical 
location 
Follow 
up 
period/ 
months 
HAART 
prior to 
study % of   
patients 
HAART (%) 
only in 
Study 
Outcome 
Categories 
Statistical 
analysis 
Standard 
methods of 
evaluation 
Limitations Notes 
Non-Union 
Closed Open 
Study Control Study Control 
S. Brijlall 
[46] 2003 R 
Africa    
(South Africa) N/M 0/18[0%]* 0/18[0%]* 
2/18[11%] 
▼  - - - N/M N/M 
Only 
radiological 
assessment. 
No control. No blinding. 
Follow up was not 
defined. Looked only at a 
cohort with infected 
implants. 
Follow up time not defined. 
Looked only at patients who were 
infected. Hence all 18 patients 
had an implant sepsis. All cases 
that were looked at were also 
delayed presentation. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
▼ Authors did not state if injuries 
were open or closed 
W.J. 
Harrison 
[42] 2004 PSB 
Africa 
(Malawi) 6 0/7[0%} 0/7[0%] - - 3/7 [43%] 1/21 [5%]  
WHO staging;      
0=4[57%],            
1=1[14%],              
2=2[29%],                    
CD4 count;                     
> 500= 2 [29%],           
200-500= 2[29%], 
>5001[14%]            
unknown 2[29%] 
P value for 
infection= 0.02 
was 
significant, for 
union=0.059 
not sig 
Only clinical 
and 
radiological 
assessment. Small study population   
W.J. 
Harrison 
[43] 2004 P 
Africa 
(Malawi) 12 0/26[0%]* 0/26[0%]* 0/26[0%] - - - 
CD4 >500=7[27%],      
200-500=8[31%], 
<200=9[35%] - 
Only clinical 
and 
radiological 
assessment. 
No control. No blinding. 
Follow up of only 12 
months, not long enough 
for long-term outcomes. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
A. 
Baburam 
[37] 2005 PSB 
Africa     
(South Africa) 4 0/14[0%]* 0/14[0%]* 0/11[0%] 0/14[0%] 1/3[33%] 0/2[0%] N/M N/M N/M 
Abstract. Follow up only 4 
months, which is not 
sufficient to measure long-
term outcomes. 
Follow up period was mentioned 
but assumed to be 4 months 
according to what is mentioned in 
abstract. 
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
S. Nawale 
[51] 2007 R Asia (India) 12 0/39[0%]* 0/39[0%]* - - 4/39 [10%] - N/M N/M 
Only clinical 
and 
radiological 
assessment. 
No control. Retrospective. 
Not blinded. Abstract.  
A. Abalo 
[30] 2010 R Africa (Togo) 27 
16/36[44%] 
▲ 
16/36[44%] 
▲ 
4/36[11%] 
▼  - - - 
CD4>500= 21[58%],     
200-500=12[33%], 
<200=3[8%] 
P value <0.05 
sig P for CD4 
counts >2 = 
0.041 - 
No control. Retrospective. 
Not blinded. 
 ▲ HAART assumed to be prior 
to injury 
▼ Authors did not state if injuries 
were open or closed 
Table 5 Click here to download Table Table 5 Nonunion in Open and Closed fractures.docx 
 Infection rates higher in 
symptomatic  
R.O.E. 
Gardner 
[48] 2012 P 
Africa 
(Malawi) 12 5/96[5%] 6/95[6%] 5/95[5%] - 1/5[20%] - 
CD4 >500=[21%],        
200-500=[64%], 
>500=[21%]                   
no relation between CD4 
and non-union N/M 
Only clinical 
and 
radiological 
assessment. No control. Not blinded.  
J. Aird [50] 2012 P 
Africa    
(South Africa) N/M 0/33[0%]* 0/33[0%]* - - 5/33[15%] 4/100[4%] N/M 
P=0.04 for 
non-union, risk 
ratio=4 N/M Not blinded. Abstract. 
Follow up period not defined.  
*No mention if patient were on 
HAART therefore assumed as 
not on HAART 
F. 
Cummins 
[49] 2014 R 
Europe 
(Republic of 
Ireland) 25 12/17[71%] 13/17[76% 3/4 [75%]  -  - 
CD4 > 500= 5,            
200-500= 12,            
>500= 0 
Correlation 
coefficient for 
complications 
and HAART 
use=-0.35 
determination= 
0.12. Non-
significant N/M 
Small cohort, area of high 
social deprivation, 
heterogeneity of the 
surgical procedures in 
emergency surgery group, 
retrospective data 
collection, and short follow 
up for two of the 
surgeries.  
M.M. 
Keetse 
[45] 2014 P 
Africa     
(South Africa) 12 12/40[3%] ■ 12/40[3%] 0/40[0%] 2/120[2%] - - 
7 patients withs 
CD4<350 N/M N/M 
Not blinded. Abstract. 
Follow up for only 
12months which is not 
enough for long term 
outcomes 
■ Time started not mentioned 
hence assumed it was prior to 
surgery 
M. Phaff 
[47] 2015 P 
Africa    
(South Africa) 
39 
(mean)   - - 
1/13 [8%] 
GA grading 
abrasions=0/3, 
I=0/6,II=0/3     
IIIa=0/0     
IIIb= 1/a 
   0/24 [0%] 
GA grading   
abrasions=0/5, 
I=0/11,      
II=0/3,       
IIIa=0/3,      
IIIb=0/2 
CD4>500=2 [15%]         
200-500= 4[31%]      
<200= 2 [15%]   
Unknown=5 [39%] N/M 
Only clinical 
and 
radiological 
assessment. 
High loss to follow-up. No 
control. Small sample 
size. Not blinded. 
 
 
Only 1 patient was on HAART at 
follow-up 
J. Hao [32] 2015 P USA (Denver) 12 22/24[92%] 22/24[92%] 1/24[4.2%] - - -  
CD4>500 =6/21,         
200-500=10/21, 
<200=5/21 N/M 
Only clinical 
and 
radiological 
assessment. 
High loss to follow-up. No 
control. Small sample 
size. Not blinded. 
Abstract. - 
Key: P – Prospective study; PSB- Prospective single blind study; R- retrospective study 
       N/M- not mentioned 
Fig 1- MeSH terms 
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Figure 1 Click here to download Figure Fig 1- MeSH terms used.docx 
Fig 2 - Flow diagram 
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